Brind.

Fosun International and Sisram Medical are leveraging a strategic ecosystem for expansion, utilizing hubs in China, North America, and Israel.

1 report, 1 independent Updated May 27
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Fosun International and Sisram Medical are leveraging a strategic ecosystem for expansion, utilizing hubs in China, North America, and Israel.

Who's involved

What this event is mainly about

How it developed

Newest first. Tap a step to see who reported it.
  1. Fosun Pharma operates in China, with innovative drugs driving its business performance.Sub-event
  2. Fosun/Sisram leverages a three-hub model (China, N. America, Israel) for global expansion.1 source

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped